
Covid-19 vaccine trials start in SA; Aspen can cope with Covid-19 wonder drug demand; SAA; CR infrastructure spend
Loading player...
In today's news headlines:
* The first clinical trial in South Africa and on the continent for a Covid-19 vaccine begins this week. The vaccine is already being evaluated in a large clinical trial in the UK where more than 4,000 participants have already been enrolled;
* South African pharmaceutical maker Aspen could provide 10 million dexamethasone tablets within a month, CEO Stephen Saad;
* South Africa’s unemployment rate rose to a 17-year high in the first quarter, even before the full impact was felt of the Covid-19 lockdown;
* President Cyril Ramaphosa says the government will galvanise R2.3bn in infrastructure investment to create about 1.8m jobs over the next decade; and
* The South African government said on Tuesday it had received unsolicited proposals from private sector funders, private equity investors and potential partners for a new national airline based on SAA.
* The first clinical trial in South Africa and on the continent for a Covid-19 vaccine begins this week. The vaccine is already being evaluated in a large clinical trial in the UK where more than 4,000 participants have already been enrolled;
* South African pharmaceutical maker Aspen could provide 10 million dexamethasone tablets within a month, CEO Stephen Saad;
* South Africa’s unemployment rate rose to a 17-year high in the first quarter, even before the full impact was felt of the Covid-19 lockdown;
* President Cyril Ramaphosa says the government will galvanise R2.3bn in infrastructure investment to create about 1.8m jobs over the next decade; and
* The South African government said on Tuesday it had received unsolicited proposals from private sector funders, private equity investors and potential partners for a new national airline based on SAA.